Estatísticas
Número total de visitas
Visualizacións | |
---|---|
Efficacy, Safety and Cost-Effectiveness of Methotrexate, Adalimumab or Their Combination in Non-infectious Non-anterior Uveitis: A Protocol for a Multicentre, Randomised, Parallel Three Arms, Active-Controlled, Phase III Open Label With Blinded Outcome Assessment Study | 68 |
Visitas ao mes
September 2023 | October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | May 2024 | June 2024 | July 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Efficacy, Safety and Cost-Effectiveness of Methotrexate, Adalimumab or Their Combination in Non-infectious Non-anterior Uveitis: A Protocol for a Multicentre, Randomised, Parallel Three Arms, Active-Controlled, Phase III Open Label With Blinded Outcome Assessment Study | 1 | 0 | 1 | 4 | 3 | 2 | 2 | 2 | 4 | 5 | 5 |
Visitas ao ficheiro
Visualizacións | |
---|---|
Calamia_Valentina_2022_Efficacy_safety_cost-effectiveness_methotrexate_adalimumab_their combination.pdf | 96 |
Países con máis visualizacións
Visualizacións | |
---|---|
United States | 32 |
Australia | 5 |
United Kingdom | 4 |
Ireland | 4 |
China | 3 |
Germany | 3 |
Spain | 2 |
Hungary | 1 |
Netherlands | 1 |
Poland | 1 |
Cidades con máis visualizacións
Visualizacións | |
---|---|
San Mateo | 6 |
Menlo Park | 4 |
Ashburn | 3 |
Dublin | 3 |
Cambridge | 2 |
Dearborn | 2 |
Mountain View | 2 |
Portsmouth | 2 |
Woodend | 2 |
Ann Arbor | 1 |